about
Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complexGenetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and LociHIV restriction in quiescent CD4⁺ T cellsCurrent aspects of vitiligo geneticsOsteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts differentiationGenome-wide association analyses identify 13 new susceptibility loci for generalized vitiligoA misexpression screen to identify regulators of Drosophila larval hemocyte development.New insights into molecular pathways associated with flatfish ovarian development and atresia revealed by transcriptional analysis.Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1).Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesisThe role of antiproliferative gene Tob1 in the immune system.Vitamin D receptor gene (VDR) transcripts in bone, cartilage, muscles and blood and microarray analysis of vitamin D responsive genes expression in paravertebral muscles of juvenile and adolescent idiopathic scoliosis patientsPhosphorylation state of a Tob/BTG protein, FOG-3, regulates initiation and maintenance of the Caenorhabditis elegans sperm fate programMolecular characterization of Tob1 in muscle development in pigsEvidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities.Biological role of the two overlapping poly(A)-binding protein interacting motifs 2 (PAM2) of eukaryotic releasing factor eRF3 in mRNA decay.Apoptosis during embryonic tissue remodeling is accompanied by cell senescence.Genomic Analyses of Sperm Fate Regulator Targets Reveal a Common Set of Oogenic mRNAs in Caenorhabditis elegansNegative regulators in homeostasis of naïve peripheral T cells.Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression.BTG/TOB factors impact deadenylases.Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions.Quiescent T cells and HIV: an unresolved relationship.Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis.Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory.Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma.C. elegans FOG-3/Tob can either promote or inhibit germline proliferation, depending on gene dosage and genetic context.Tob1 is expressed in developing and adult gonads and is associated with the P-body marker, Dcp2.Transducer of erbB2.1 is a potential cellular target of gefitinib in lung cancer therapy.Structural basis for inhibition of the Tob-CNOT7 interaction by a fragment screening approach.IL-4-induced gene 1 maintains high Tob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells.
P2860
Q24315834-0849F8C1-D879-4CAE-8E49-49E0FC6F649CQ26766384-93541EA3-FF6E-4FB7-A279-C3109C06E132Q26995784-1DCB0067-457F-4A13-9DF0-D90DF847BCC4Q27003993-A1F77EFC-9A58-4EBF-AB32-530D67DB76C9Q28505310-A640B41B-823E-47CC-A4C8-9CA163200024Q28924362-1D150E0B-AA25-41EE-BCBB-562E5513A3C7Q33364881-B8A969D7-6267-4F3C-865B-9A6A7DDF629DQ33503416-3EB1E3E1-C7B9-450E-B911-C2A63C14BCF7Q33567280-86FF898E-44A0-4FAE-90B1-16659C7919A1Q33779715-ADEC2CB0-13CD-4606-96C9-C9992C480464Q33951429-757AE2B0-5307-46CF-8090-1463D62DC0C5Q34520064-DC46BD1B-D47D-4BF8-AECD-EB28C2CCFE56Q35021830-655BDB49-56DF-447A-AF36-98391E52A5B1Q35162113-7E2F6BF0-790B-49FA-A471-65410E31818BQ35806667-36C95032-4A37-4926-8ED0-2D30C3A16B21Q36342225-D88DBBAC-C46B-4858-B333-E0511C3BC5FBQ36411115-553378C8-5BEB-4A07-8AF4-28C1E7C1AAC9Q36429798-4EEC28FF-43FB-4961-8B48-B90E15058E1AQ36983409-7D1B6AEE-F533-4FB7-9CBC-D22D5FA50339Q37409167-822F61E3-C87F-4CFB-B7AB-D4F760E39F05Q37455743-D720C332-8D13-4EAF-A1BD-A5A6DD7470E9Q37580229-4F63FC8B-AAF2-4A13-A2F5-B15B8DDE4D15Q37781304-8794BEEA-7365-4A61-A0AC-81A77BA8DD54Q38457923-9ADFC317-660D-4812-B609-A237BC789458Q38574697-B86A8F68-0E1E-4DCB-B4B2-409E710C4422Q38913245-EC2B0591-2931-4812-9CFC-75701869DF47Q39119017-385E0662-A226-4D8E-AB63-0DA46430C332Q40337342-4517B52B-32D0-4208-B874-2346D8CC8B8EQ42416926-46CD603F-3295-4E76-8799-082BBE2BC146Q43159958-269C5BE7-E4A9-4EFE-AD03-5BF613DD54EEQ54392412-A30B4E09-F3EF-4326-BECD-341F4EEBE124
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tob genes in development and homeostasis.
@ast
Tob genes in development and homeostasis.
@en
type
label
Tob genes in development and homeostasis.
@ast
Tob genes in development and homeostasis.
@en
prefLabel
Tob genes in development and homeostasis.
@ast
Tob genes in development and homeostasis.
@en
P2860
P356
P1476
Tob genes in development and homeostasis.
@en
P2093
Anming Meng
Shunji Jia
P2860
P304
P356
10.1002/DVDY.21092
P577
2007-04-01T00:00:00Z